Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Visca

Showing results (21-30 of 287) with videos related to

Pageof 29
Sort By:
Frontiers in Microbiology|May 6, 2014
Antivirulence activity of azithromycin in Pseudomonas aeruginosaFrancesco Imperi, Livia Leoni, Paolo Visca
Molecular Microbiology|December 1, 2007
Intracellular levels and activity of PvdS, the major iron starvation sigma factor of Pseudomonas aeruginosaFederica Tiburzi, Francesco Imperi, Paolo Visca
Trends in Microbiology|November 23, 2006
Pyoverdine siderophores: from biogenesis to biosignificancePaolo Visca, Francesco Imperi, Iain L Lamont
IUBMB Life|October 19, 2011
Acinetobacter infection--an emerging threat to human healthPaolo Visca, Harald Seifert, Kevin J Towner
Biochemical and Biophysical Research Communications|December 20, 2003
Expression of L-ornithine Ndelta-oxygenase (PvdA) in fluorescent Pseudomonas species: an immunochemical and in silico studyLorenza Putignani, Cecilia Ambrosi, Paolo Ascenzi, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2008
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumanniiAlessandro Capone, Silvia D'Arezzo, Paolo Visca, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2015
Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serumCarlo Bonchi, Emanuela Frangipani, Francesco Imperi, et al.
Frontiers in Microbiology|April 26, 2021
Editorial: XXXIII SIMGBM Congress 2019 - Antimicrobials and Host-Pathogen InteractionsFlavia Marinelli, Pietro Alifano, Paolo Landini, et al.
Chemosphere|November 26, 2005
Cyanide detoxification by recombinant bacterial rhodaneseRita Cipollone, Paolo Ascenzi, Emanuela Frangipani, et al.
Emerging Topics in Life Sciences|February 2, 2021
Drug repurposing for antivirulence therapy against opportunistic bacterial pathogensGiordano Rampioni, Paolo Visca, Livia Leoni, et al.
Pageof 29

Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
Frontiers in Microbiology|May 6, 2014
Antivirulence activity of azithromycin in Pseudomonas aeruginosaFrancesco Imperi, Livia Leoni, Paolo Visca
Molecular Microbiology|December 1, 2007
Intracellular levels and activity of PvdS, the major iron starvation sigma factor of Pseudomonas aeruginosaFederica Tiburzi, Francesco Imperi, Paolo Visca
Trends in Microbiology|November 23, 2006
Pyoverdine siderophores: from biogenesis to biosignificancePaolo Visca, Francesco Imperi, Iain L Lamont
IUBMB Life|October 19, 2011
Acinetobacter infection--an emerging threat to human healthPaolo Visca, Harald Seifert, Kevin J Towner
Biochemical and Biophysical Research Communications|December 20, 2003
Expression of L-ornithine Ndelta-oxygenase (PvdA) in fluorescent Pseudomonas species: an immunochemical and in silico studyLorenza Putignani, Cecilia Ambrosi, Paolo Ascenzi, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2008
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumanniiAlessandro Capone, Silvia D'Arezzo, Paolo Visca, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2015
Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serumCarlo Bonchi, Emanuela Frangipani, Francesco Imperi, et al.
Frontiers in Microbiology|April 26, 2021
Editorial: XXXIII SIMGBM Congress 2019 - Antimicrobials and Host-Pathogen InteractionsFlavia Marinelli, Pietro Alifano, Paolo Landini, et al.
Chemosphere|November 26, 2005
Cyanide detoxification by recombinant bacterial rhodaneseRita Cipollone, Paolo Ascenzi, Emanuela Frangipani, et al.
Emerging Topics in Life Sciences|February 2, 2021
Drug repurposing for antivirulence therapy against opportunistic bacterial pathogensGiordano Rampioni, Paolo Visca, Livia Leoni, et al.
Pageof 29